**Question:** Sirolimus is more likely than cyclosporine to cause

A. nephrotoxicity
B. neurotoxicity
C. hyperlipidemia
D. interstitial pneumonia

**Core Concept:** Sirolimus and cyclosporine are both calcineurin inhibitors used as immunosuppressive agents in organ transplant recipients and other immunocompromised patients. However, they differ in their pharmacokinetics, pharmacodynamics, and side effect profiles.

**Why the Correct Answer is Right:** Sirolimus, also known as rapamycin, has a unique pharmacokinetic profile due to its lipophilicity and slow elimination, leading to a more prolonged suppression of T-cell activation. This results in a reduced risk of acute rejection in organ transplant recipients but also increases the risk of certain adverse effects.

A. **Nephrotoxicity:** Sirolimus, particularly in higher doses, can cause nephrotoxicity due to its effect on vascular smooth muscle cells and endothelial cells, leading to renal vasoconstriction, ischemia, and potential acute kidney injury. This is less common with cyclosporine, which is primarily nephrotoxic due to its direct tubular toxicity.

B. **Neurotoxicity:** Both drugs can cause neurotoxicity, but the incidence is generally higher with cyclosporine. This is attributed to its direct effect on neural cells and disruption of blood-brain barrier integrity. Sirolimus is generally less neurotoxic compared to cyclosporine.

C. **Hyperlipidemia:** Sirolimus is associated with hyperlipidemia due to its effect on lipoprotein lipase and hepatic lipoprotein synthesis, leading to increased triglyceride and cholesterol levels. This is less common with cyclosporine.

D. **Interstitial Pneumonitis:** Cyclosporine is associated with interstitial pneumonia due to its direct toxicity to alveolar macrophages and alveolar epithelial cells. Sirolimus is associated with pneumonitis, but the incidence is generally lower than cyclosporine.

**Why Each Wrong Option is Incorrect:**

A. **Nephrotoxicity (cyclosporine):** Cyclosporine is directly nephrotoxic due to its effect on renal tubular cells, leading to tubulointerstitial nephritis and tubular dysfunction.

B. **Neurotoxicity (both):** Both drugs can cause neurotoxicity, but as mentioned before, the incidence is generally higher with cyclosporine due to its direct effect on neural cells and disruption of the blood-brain barrier integrity.

C. **Hyperlipidemia (cyclosporine):** Cyclosporine is associated with hyperlipidemia due to its effect on lipoprotein lipase and hepatic lipoprotein synthesis, leading to increased triglyceride and cholesterol levels.

D. **Interstitial Pneumonitis (both):** Both drugs can cause interstitial pneumonitis due to their effects on alveolar macrophages and alveolar epithelial cells. However, as mentioned, the incidence is generally lower with sirolimus due to its unique pharmacology and pharmacokinetics.

**Clin